What is the main purpose of this 8-K filing by Boston Scientific?

The main purpose of this 8-K filing is to officially release and provide access to Boston Scientific's financial results for the first quarter ended March 31, 2024, through an accompanying press release.

Where can I find the detailed financial results for Q1 2024?

The detailed financial results are contained within the press release that is furnished as Exhibit 99.1 to this 8-K filing. Investors should refer to that document for specific revenue, earnings, and other financial information.

Does this 8-K filing contain forward-looking guidance or outlook?

This 8-K filing itself does not contain the detailed guidance. However, the accompanying press release (Exhibit 99.1) is the typical place where companies provide updates on their financial outlook and guidance for the upcoming periods. Investors should review the press release for this information.

What does it mean that the information is 'furnished' and not 'filed'?

This is a standard disclosure. When information is 'furnished' under Item 2.02, it means the company is providing it to the SEC but it is not subject to the same liability provisions as information that is formally 'filed' under other sections of the Exchange Act, such as Section 18. It does not become automatically incorporated by reference into other SEC filings unless explicitly stated.

BSX 8-K: Earnings & Results

Summary

Boston Scientific Corporation (BSX) filed an 8-K on April 24, 2024, primarily to furnish a press release detailing its financial results for the first quarter ended March 31, 2024. This filing signals the official release of the company's performance metrics for the period. Investors should refer to the furnished press release (Exhibit 99.1) for the specific details regarding revenue, earnings, and any updated financial guidance or operational highlights. The key takeaway for investors is that the company has disclosed its Q1 2024 financial performance. While the 8-K itself does not contain the detailed financial data, it directs stakeholders to the accompanying press release. Therefore, a thorough review of the press release is essential for a comprehensive understanding of Boston Scientific's current financial standing and future outlook.

Key Highlights

1Boston Scientific Corporation filed an 8-K on April 24, 2024.
2The filing's primary purpose is to announce and furnish the company's Q1 2024 financial results.
3The detailed financial results are provided in a press release, furnished as Exhibit 99.1.
4Investors should consult Exhibit 99.1 for specific Q1 2024 performance data and commentary.
5The information furnished is not deemed 'filed' for Section 18 purposes, a standard disclaimer.
6Includes the Cover Page Interactive Data File (XBRL) as Exhibit 104.

BOSTON SCIENTIFIC CORP 8-K Report, Financial Results (Apr 24, 2024)

Summary

Key Highlights

Frequently Asked Questions